[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-350614-en":59,"doc-seo-350614-105":99},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":72,"language":73,"language_code":74,"site_id":75,"html_lang":74,"table_of_contents":76,"faqs":77,"seo_title":78,"seo_description":66,"update_tm":79,"read_time":80,"preview_page_count":19,"preview_urls":81},350614,687212321768,"Guten tag","https://ap-avatar.wpscdn.com/avatar/a0010bdbe886d2fe77?x-image-process=image/resize,m_fixed,w_180,h_180&k=1789897067658708522","Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies - insights from the myositis audit and research collaborative group","International multicentre audit of malignancy screening practices in idiopathic inflammatory myopathies (IIM) versus IMACS recommendations, using a real-world cohort. Retrospective data from eight centres in seven countries/regions stratified patients by IMACS cancer risk categories and compared historical screening with guideline-recommended tests. Among 795 patients, most were classified high, moderate, or standard risk, with malignancy developing in 10.8% within 3 years. Independent cancer predictors included TIF1γ positivity, smoking, night sweats, and older age, while anti-Mi2 antibodies and non-dermatomyositis subtypes were protective.","Myositis  \nORIGINAL RESEARCH  \nMulticentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from the myositis audit and research collaborative group  \nJessica Day  ,1,2,3 Lekshmi Minikumari Rahulan  ,4 Samuel Katsuyuki Shinjo,5 Fernanda Oliveira de Andrade Lopes,5 Akira Yoshida  ,6 Shintaro Yamamoto  ,6 Maria Rosa Pellico,7,8 Shereen Oon,2,3 Ian Teh,1 Pallavi Vij,9 Iris Tang,10  \nEdmund Wong,11 Aman Kumar,9 Nicoletta Del Papa  ,7,8 Roberto Caporali  ,7,8 Ho So,12 Vahed Maroufy,13 Masataka Kuwana  ,6 Vikas Agarwal  ,4  \nLatika Gupta  9,14,15  \nTo cite: Day J, Minikumari Rahulan L, Shinjo SK, et al. Multicentre  \ninternational audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies: insights from themyositis audit and research collaborative group. RMD Open 2026;12:e006373 . doi:10 . 1136/ rmdopen-2025-006373  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[rmdopen-2025-006373](rmdopen-2025-006373)) .  \nJD and LMR contributed equally.  \nReceived 24 September 2025 Accepted 22 June 2026  \n© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.  \nFor numbered affiliations see end of article.  \nCorrespondence to  \nDr Latika Gupta; [l.gupta@bham.ac.uk](l.gupta@bham.ac.uk)  \nABSTRACT  \nBackground Consensus guidelines for malignancy screening in idiopathic inflammatory myopathy (IIM) were recently published by the International Myositis Assessment and Clinical Studies (IMACS) working group. This international multicentre study audited historical cancer screening practices against IMACS recommendations and examined the distribution of observed malignancies across IMACS-defined risk categories in a real-world cohort.  \nMethods This retrospective study included patients with IIM from eight centres across seven countries/regions. Patients were stratified using IMACS-defined cancer risk categories. Historical screening was compared  \nwith the guideline recommendations. Multivariable logistic regression identified predictors of cancer and underscreening.  \nResults Of the 795 patients (72 .3% female), 51 .7%, 37.9% and 10.4% were classified as high risk, moderate risk and standard risk, respectively. Across all sites, few high-risk (6 .2%), moderate-risk (2 .7%) and standardrisk (11 . 1%) patients underwent a full panel of IMACSrecommended tests. Within 3 years of diagnosis, 86 patients (10 .8%) developed malignancy. Among observed cancers, 77.4% occurred in high-risk and 22.6% in moderate-risk patients, with none detected in the standard-risk group. Anti-transcription intermediary factor 1-gamma (TIF1γ) positivity (OR 4.64, 95% CI 2.35 to 9 . 16, p\u003C0 .001), smoking (OR 3 .00, 95% CI 1.64 to 5.50, p\u003C0 .001), night sweats (OR 12 .76, 95% CI 2.72 to 59 .87, p=0 .001) and increasing age (OR 1.05 95% CI 1.03 to 1.07 per year, p\u003C0 .001) were independently associated with cancer, whereas anti-Mi2 antibodies and non-dermatomyositis subtypes were protective. Cancer risk increased with each additional high-risk feature (OR 1 .70) and decreased with each low-risk feature (OR 0 .76) . Underscreened individuals had lower rates of immune-mediated necrotising myopathy (5 .6% vs 14.3%,  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Idiopathic inflammatory myopathy (IIM) is associated with an increased risk of malignancy, especially in certain subgroups.\u003Cbr>⇒ Screening practices have historically been variable and non-standardised.\u003Cbr>⇒ The International Myositis Assessment and Clinical Studies (IMACS) group recently proposed consensus guidelines, but their performance in real-world cohorts was unknown.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ Most detected cancers occurred in patients retrospectively classified as high risk under the IMACS framework,","cbCaigjxhX1x5wX1","https://ap.wps.com/l/cbCaigjxhX1x5wX1","pdf",1273571,13,"English","en",105,"# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Idiopathic inflammatory myopathies and cancer risk","[{\"question\":\"What was the study’s main objective regarding IMACS recommendations?\",\"answer\":\"To audit historical cancer screening practices against IMACS guideline recommendations in a real-world cohort and assess how observed malignancies distributed across IMACS-defined risk categories.\"},{\"question\":\"How were patients classified in the analysis?\",\"answer\":\"Patients with IIM from eight centres were stratified using IMACS-defined cancer risk categories, then historical screening was compared with recommended tests.\"},{\"question\":\"Which factors were independently associated with cancer in idiopathic inflammatory myopathies?\",\"answer\":\"Anti-transcription intermediary factor 1-gamma (TIF1γ) positivity, smoking, night sweats, and increasing age were independently associated with cancer, while anti-Mi2 antibodies and non-dermatomyositis subtypes were protective.\"}]","Multicentre international audit of IMACS malignancy screening guidelines in idiopathic inflammatory myopathies - insights from the myositis audit and research collaborative group | PDF",1790089896,33,[82,86,90,95],{"page_no":8,"url":83,"width":84,"height":85},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed957a579b12e2fe594e74df2a758648.webp",983,1310,{"page_no":14,"url":87,"width":88,"height":89},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/957d86cd09d4cc7b6fc1d01bec74d117.webp",982,1309,{"page_no":91,"url":92,"width":93,"height":94},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3e4cd6efb4987660df3cc605edd0557.webp",981,1308,{"page_no":19,"url":96,"width":97,"height":98},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7d0a81d6d504cc92b83123968e5f9908.webp",980,1306,{"code":4,"msg":100,"data":101},"ok",{"site_id":75,"language":74,"slug":102,"title":65,"keywords":103,"description":66,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"multicentre-international-audit-of-imacs-malignancy-screening-guidelines-in-idiopathic-inflammatory-myopathies-insights-from-the-myositis-audit-and-research-collaborative-group","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":9,"@type":112,"position":14},"https://docshare.wps.com/document/",{"item":116,"name":40,"@type":112,"position":91},"https://docshare.wps.com/document/research-report/",{"item":118,"name":65,"@type":112,"position":19},"https://docshare.wps.com/document/multicentre-international-audit-of-imacs-malignancy-screening-guidelines-in-idiopathic-inflammatory-myopathies-insights-from-the-myositis-audit-and-research-collaborative-group/350614/",{"url":118,"name":65,"@type":120,"image":121,"author":126,"headline":65,"publisher":128,"fileFormat":131,"inLanguage":74,"description":66,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/multicentre-international-audit-of-imacs-malignancy-screening-guidelines-in-idiopathic-inflammatory-myopathies-insights-from-the-myositis-audit-and-research-collaborative-group/350614.png","ImageObject",300,407,{"name":63,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-10-25","2026-09-22",true,{"@type":136,"interactionType":137,"userInteractionCount":52},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"What was the study’s main objective regarding IMACS recommendations?","Question",{"text":146,"@type":147},"To audit historical cancer screening practices against IMACS guideline recommendations in a real-world cohort and assess how observed malignancies distributed across IMACS-defined risk categories.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"How were patients classified in the analysis?",{"text":151,"@type":147},"Patients with IIM from eight centres were stratified using IMACS-defined cancer risk categories, then historical screening was compared with recommended tests.",{"name":153,"@type":144,"acceptedAnswer":154},"Which factors were independently associated with cancer in idiopathic inflammatory myopathies?",{"text":155,"@type":147},"Anti-transcription intermediary factor 1-gamma (TIF1γ) positivity, smoking, night sweats, and increasing age were independently associated with cancer, while anti-Mi2 antibodies and non-dermatomyositis subtypes were protective.","https://schema.org",{"og:url":118,"og:type":158,"og:title":65,"og:site_name":129,"og:description":66},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":61,"site_id":75},1790535031]